These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30704571)
1. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes. Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571 [TBL] [Abstract][Full Text] [Related]
2. Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical Trials. Gaba P; Christiansen EH; Nielsen PH; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Stone GW; Sabik JF; Sabatine MS; Holm NR; Bergmark BA JAMA Cardiol; 2023 Jul; 8(7):631-639. PubMed ID: 37256598 [TBL] [Abstract][Full Text] [Related]
3. Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization. Farkouh ME; Godoy LC; Brooks MM; Mancini GBJ; Vlachos H; Bittner VA; Chaitman BR; Siami FS; Hartigan PM; Frye RL; Boden WE; Fuster V J Am Coll Cardiol; 2020 Nov; 76(19):2197-2207. PubMed ID: 33153578 [TBL] [Abstract][Full Text] [Related]
4. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials. Baber U; Giustino G; Sartori S; Aquino M; Stefanini GG; Steg PG; Windecker S; Leon MB; Wijns W; Serruys PW; Valgimigli M; Stone GW; Dangas GD; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari D; Von Birgelen C; Mastoris I; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R JACC Cardiovasc Interv; 2016 Jan; 9(1):28-38. PubMed ID: 26762908 [TBL] [Abstract][Full Text] [Related]
5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702 [TBL] [Abstract][Full Text] [Related]
6. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148 [TBL] [Abstract][Full Text] [Related]
7. Education programmes for people with chronic kidney disease and diabetes. Cashmore BA; Cooper TE; Evangelidis NM; Green SC; Lopez-Vargas P; Tunnicliffe DJ Cochrane Database Syst Rev; 2024 Aug; 8(8):CD007374. PubMed ID: 39171639 [TBL] [Abstract][Full Text] [Related]
8. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial. Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953 [TBL] [Abstract][Full Text] [Related]
9. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP Lancet; 2018 Mar; 391(10124):939-948. PubMed ID: 29478841 [TBL] [Abstract][Full Text] [Related]
10. Interventions to increase patient and family involvement in escalation of care for acute life-threatening illness in community health and hospital settings. Mackintosh NJ; Davis RE; Easter A; Rayment-Jones H; Sevdalis N; Wilson S; Adams M; Sandall J Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012829. PubMed ID: 33285618 [TBL] [Abstract][Full Text] [Related]
11. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation. Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138 [TBL] [Abstract][Full Text] [Related]
12. Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass Surgery: A Pooled Analysis of 2 Randomized Clinical Trials. Holm J; Vanky F; Svedjeholm R JAMA Netw Open; 2024 Jan; 7(1):e2351743. PubMed ID: 38252440 [TBL] [Abstract][Full Text] [Related]
13. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
14. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
16. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
17. Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy. Otsuki H; Takahashi K; Zimmermann FM; Mavromatis K; Aminian A; Jagic N; Dambrink JE; Kala P; MacCarthy P; Witt N; Kobayashi Y; Takahashi T; Woo YJ; Yeung AC; De Bruyne B; Pijls NHJ; Fearon WF; Circ Cardiovasc Interv; 2024 Nov; 17(11):e014300. PubMed ID: 39502029 [TBL] [Abstract][Full Text] [Related]
18. Antioxidants for adults with chronic kidney disease. Colombijn JM; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RW Cochrane Database Syst Rev; 2023 Nov; 11(11):CD008176. PubMed ID: 37916745 [TBL] [Abstract][Full Text] [Related]
19. Impact of Coronary Chronic Total Occlusion Revascularization Strategy on 30-Day Outcomes in Patients with Left Ventricular Systolic Dysfunction. Zhang Y; Wu Z; Wang S; Liu J Int Heart J; 2024 Nov; 65(6):987-995. PubMed ID: 39537164 [TBL] [Abstract][Full Text] [Related]